Informational Tool for Smoking Cessation in COPD Patients

Recruiting

• Conditions: Chronic Obstructive Pulmonary Disease (COPD)

• Registration Number: NCT06872450
• Lead Sponsor: Hopital Nord Franche-Comte

Brief Summary

Chronic obstructive pulmonary disease (COPD) is a lung disease that affects nearly 8% of the adult population and causes 18,000 deaths per year in France. The most frequent cause of this pathology is smoking. COPD patients who stop smoking have a better quality of life, a marked a significant slowdown in disease progression and an increased life expectancy. Investigators propose to carry out a quantitative study among patients smokers suffering from COPD, by setting up a tool in the form of an motivational intervention specific to this population.

Detailed Description

implementing a tool in the form of an informational intervention with a specific motivational intervention

Study Timeline

• Status Verified: 2025-02
• Study Start: 2025-02-14
• Study First Submitted: 2025-02-25
• Study First Submitted QC: 2025-03-10
• Study First Posted: 2025-03-12
• Last Update Submitted: 2025-03-18
• Last Update Posted: 2025-03-20
• Primary Completion: 2025-06-14
• Study Completion: 2025-06-14

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• People suffering from chronic obstructive pulmonary disease (COPD) stage 2/3
• People treated at HNFC
• Smokers

Exclusion Criteria

• People with cognitive disorders compromising comprehension and completion of the study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
motivational effectiveness	60 days	Degree of dependence (Fagerström test)

Trial Locations

Locations (1)

Hôpital Nord Franche-comté; 🇫🇷 Trevenans, France